This content is machine translated Mantle cell lymphoma Recurrence after BTK inhibition – prognostic factors and treatment options Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin’s lymphoma with a markedly heterogeneous course. The spectrum ranges from indolent, slowly progressive forms to highly aggressive variants. Diagnosis and treatment...…
View Post 11 min This content is machine translated Modern system therapeutics for hidradenitis suppurativa Immunological dysregulation in the sights of several biologics and “small molecules” The approval of anti-TNF and anti-IL-17 antibody therapies for moderate to severe courses of hidradenitis suppurativa has significantly improved the drug treatment options for this debilitating and potentially mutilating disease...…
View Post 8 min This content is machine translated Mastocytosis Innovative pathogenesis-based therapeutic approaches in the pipeline The treatment of mastocytosis has undergone a paradigm shift in recent years. A deeper molecular understanding of the disease has paved the way from a purely symptomatic to a targeted,...…
